FeesSafety
Pluang+

Societe Generale reports 739 million shares and 821 million voting rights as of Sept 30, 2026.

Company Fundamentals
08 Oct 2026, 23:00 WIB
Na
View Source
Neutral
Societe Generale reports 739 million shares and 821 million voting rights as of Sept 30, 2026.

As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries. Societe Generale continues to focus on sustainable value creation and ESG initiatives, maintaining its position in major socially responsible investment indices. This update follows the completion of a €1.5 billion share buy-back program aimed at canceling shares to optimize capital structure.

Societe Generale's shares and voting rights as of September 30, 2026, provide context for this financial update. For readers following Financials-sector stocks, here is Pluang's market snapshot as of Oct 08, 2026 23:21 WIB: out of 118 priced US Financials stocks, 36 rose and 82 fell. Notable movers include MARA at USD 9.90 with a 1-day change of -4.44% and a typical hold time on Pluang of 21 days, GEMI at USD 4.36 down 2.90% with a 14-day hold time, and PSEC at USD 1.79 down 2.72% with a 78-day hold time and 38% sell / 62% buy order activity.

More News

Valneva's chikungunya vaccine IXCHIQ® shows 94% antibody persistence five years after one dose

Valneva's chikungunya vaccine IXCHIQ® shows 94% antibody persistence five years after one dose

Valneva announced that 94% of participants maintained a strong antibody response five years after a single dose of its chikungunya vaccine IXCHIQ®. The vaccine showed durable immunity across all age groups, including adults over 65, supporting its po...

Market News
Bullish
25 minutes ago
Roche unveils new Alzheimer’s drug and diagnostic data at CTAD 2026, advancing treatment and early detection.

Roche unveils new Alzheimer’s drug and diagnostic data at CTAD 2026, advancing treatment and early detection.

Roche presented new data on its Alzheimer’s disease portfolio at the CTAD 2026 conference, highlighting advances in both pharmaceuticals and diagnostics. Key updates include Phase Ib/IIa data for trontinemab showing rapid amyloid clearance, the start...

Market News
Bullish
25 minutes ago
Ethereum price dips to $2,120 amid ETF outflows and large holder activity.

Ethereum price dips to $2,120 amid ETF outflows and large holder activity.

Ethereum's price fell to $2,120 on November 10, continuing recent losses driven by $184.51 million in U.S. spot ETF outflows and notable selling by an Ethereum Foundation-linked wallet. Despite a nearly flat broader crypto market, Ethereum underperfo...

Market News
Bearish
5 hours ago
South Korea's Upbit and Bithumb list Hyperliquid (HYPE), sparking a slight price rise amid a falling crypto market.

South Korea's Upbit and Bithumb list Hyperliquid (HYPE), sparking a slight price rise amid a falling crypto market.

South Korea's largest crypto exchanges, Upbit and Bithumb, began trading Hyperliquid (HYPE) on November 10, listing it in their Korean won markets. Despite a general crypto market decline of 2.47%, HYPE's price rose by 0.73%, though it remains over 1...

Market News
Bullish
5 hours ago
Wix reports Q3 2026 revenue up 13% driven by Base44 growth and launches AI-powered Studio Two.

Wix reports Q3 2026 revenue up 13% driven by Base44 growth and launches AI-powered Studio Two.

Wix.com reported Q3 2026 revenue of $570 million, a 13% year-over-year increase, fueled by strong performance from its Base44 platform, which is nearing $250 million in annual recurring revenue. The company launched Studio Two, an advanced AI-powered...

Company Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App